Skip to search formSkip to main content

microbisporicin

Known as: lantibiotic 107891 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
The intrinsic qualities of lanthipeptides for their use as therapeutic drugs present several challenges because of their… Expand
Is this relevant?
2015
2015
Microbisporicin is a potent type I lantibiotic produced by the rare actinomycete Microbispora corallina that is in preclinical… Expand
  • figure 1
  • table 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
With the increasing need of effective antibiotics against multi-drug resistant pathogens, lantibiotics are an attractive option… Expand
  • table 1
  • table 2
  • figure 1
  • figure 1
  • table 3
Is this relevant?
2015
2015
The increasing resistance of bacteria to conventional antimicrobial therapy within both the nosocomial and community environment… Expand
  • figure 1
  • table 1
Is this relevant?
2011
2011
Lantibiotics are ribosomally synthesized, posttranslationally modified peptide antibiotics. Microbisporicin is a potent… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Lantibiotics are ribosomally synthesized, posttranslationally modified peptide antibiotics. The biosynthetic gene cluster for… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Antibiotics blocking bacterial cell wall assembly (beta-lactams and glycopeptides) are facing a challenge from the progressive… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?